FGFR-话题@MedSci

#FGFR#

30篇内容 | 1677人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1483064, encodeId=abf51483064d7, content=<a href='/topic/show?id=5dcbe397d2' target=_blank style='color:#2F92EE;'>#FGFR#</a>, objectTitle=Sci Rep：Runx2是成骨细胞祖细胞增殖所必需的，通过调节Fgfr2和Fgfr3诱导细胞增殖, objectType=article, longId=148979, objectId=a5e71489e93b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5e71489e93b, replyNumber=0, likeNumber=79, createdTime=2018-09-18, rootId=0, userName=12498c24m71暂无昵称, userId=31fb7872570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5e71489e93b, moduleTitle=Sci Rep：Runx2是成骨细胞祖细胞增殖所必需的，通过调节Fgfr2和Fgfr3诱导细胞增殖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5e71489e93b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483063, encodeId=d0ad14830637c, content=<a href='/topic/show?id=5dcbe397d2' target=_blank style='color:#2F92EE;'>#FGFR#</a>, objectTitle=JCO：BGJ398治疗FGFR改变晚期胆管癌, objectType=article, longId=121790, objectId=0dc5121e9000, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dc5121e9000, replyNumber=0, likeNumber=67, createdTime=2017-12-01, rootId=0, userName=12498c24m71暂无昵称, userId=31fb7872570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dc5121e9000, moduleTitle=JCO：BGJ398治疗FGFR改变晚期胆管癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0dc5121e9000)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483062, encodeId=d61b148306256, content=<a href='/topic/show?id=5dcbe397d2' target=_blank style='color:#2F92EE;'>#FGFR#</a>, objectTitle=重磅：肝癌在研新药FGFR4抑制剂获FDA孤儿药资格, objectType=article, longId=115959, objectId=a625115959e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a625115959e8, replyNumber=0, likeNumber=66, createdTime=2017-10-14, rootId=0, userName=12498c24m71暂无昵称, userId=31fb7872570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a625115959e8, moduleTitle=重磅：肝癌在研新药FGFR4抑制剂获FDA孤儿药资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a625115959e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483061, encodeId=5225148306108, content=<a href='/topic/show?id=5dcbe397d2' target=_blank style='color:#2F92EE;'>#FGFR#</a>, objectTitle=CLIN CANCER RES：FGFR1过表达肺癌原发耐药机制, objectType=article, longId=113919, objectId=e159113919ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e159113919ed, replyNumber=0, likeNumber=0, createdTime=2017-09-25, rootId=0, userName=12498c24m71暂无昵称, userId=31fb7872570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e159113919ed, moduleTitle=CLIN CANCER RES：FGFR1过表达肺癌原发耐药机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e159113919ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483060, encodeId=e52914830609d, content=<a href='/topic/show?id=5dcbe397d2' target=_blank style='color:#2F92EE;'>#FGFR#</a>, objectTitle=CLIN CANCER RES：多韦替尼治疗BCG无反应FGFR3突变或过表达尿路上皮肿瘤Ⅱ期临床试验结果, objectType=article, longId=104352, objectId=9efe10435266, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9efe10435266, replyNumber=0, likeNumber=56, createdTime=2017-07-04, rootId=0, userName=12498c24m71暂无昵称, userId=31fb7872570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9efe10435266, moduleTitle=CLIN CANCER RES：多韦替尼治疗BCG无反应FGFR3突变或过表达尿路上皮肿瘤Ⅱ期临床试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9efe10435266)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483059, encodeId=0e5c1483059e6, content=<a href='/topic/show?id=5dcbe397d2' target=_blank style='color:#2F92EE;'>#FGFR#</a>, objectTitle=BMC Cancer：FGFR1和FRS2α的表达增加会降低RCC患者的无进展生存期, objectType=article, longId=50059, objectId=70ba50059c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70ba50059c4, replyNumber=0, likeNumber=57, createdTime=2015-05-01, rootId=0, userName=12498c24m71暂无昵称, userId=31fb7872570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70ba50059c4, moduleTitle=BMC Cancer：FGFR1和FRS2α的表达增加会降低RCC患者的无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70ba50059c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483058, encodeId=f74c14830582a, content=<a href='/topic/show?id=5dcbe397d2' target=_blank style='color:#2F92EE;'>#FGFR#</a>, objectTitle=Hepatology：miR-214下调FGFR1抑制结直肠癌肝转移, objectType=article, longId=32471, objectId=a0a2324e110, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0a2324e110, replyNumber=0, likeNumber=57, createdTime=2014-03-29, rootId=0, userName=12498c24m71暂无昵称, userId=31fb7872570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0a2324e110, moduleTitle=Hepatology：miR-214下调FGFR1抑制结直肠癌肝转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0a2324e110)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483057, encodeId=d1b2148305ef3, content=<a href='/topic/show?id=5dcbe397d2' target=_blank style='color:#2F92EE;'>#FGFR#</a>, objectTitle=PNAS：FGFR4 ，MAP3K9和PAK5可能成为非小细胞肺癌（NSCLC）的潜在治疗靶点, objectType=article, longId=21322, objectId=2d5c21322c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d5c21322c6, replyNumber=0, likeNumber=55, createdTime=2013-07-14, rootId=0, userName=12498c24m71暂无昵称, userId=31fb7872570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d5c21322c6, moduleTitle=PNAS：FGFR4 ，MAP3K9和PAK5可能成为非小细胞肺癌（NSCLC）的潜在治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d5c21322c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483056, encodeId=28bc1483056d4, content=<a href='/topic/show?id=5dcbe397d2' target=_blank style='color:#2F92EE;'>#FGFR#</a>, objectTitle=Science：转化性FGFR-TACC基因融合引发恶性胶质母细胞瘤, objectType=article, longId=8275, objectId=6f5a82e5e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f5a82e5e3, replyNumber=0, likeNumber=56, createdTime=2012-07-29, rootId=0, userName=12498c24m71暂无昵称, userId=31fb7872570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f5a82e5e3, moduleTitle=Science：转化性FGFR-TACC基因融合引发恶性胶质母细胞瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f5a82e5e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483055, encodeId=11d514830555d, content=<a href='/topic/show?id=5dcbe397d2' target=_blank style='color:#2F92EE;'>#FGFR#</a>, objectTitle=PLoS ONE：阻断FGFR抑制肿瘤转移, objectType=article, longId=7666, objectId=da37e666a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da37e666a8, replyNumber=0, likeNumber=60, createdTime=2012-07-08, rootId=0, userName=12498c24m71暂无昵称, userId=31fb7872570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da37e666a8, moduleTitle=PLoS ONE：阻断FGFR抑制肿瘤转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da37e666a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483054, encodeId=e5a0148305449, content=<a href='/topic/show?id=5dcbe397d2' target=_blank style='color:#2F92EE;'>#FGFR#</a>, objectTitle=PLoS One：FGFR1诱导肿瘤上皮间质转化机制, objectType=article, longId=7534, objectId=7249e53419, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7249e53419, replyNumber=0, likeNumber=119, createdTime=2012-07-04, rootId=0, userName=12498c24m71暂无昵称, userId=31fb7872570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7249e53419, moduleTitle=PLoS One：FGFR1诱导肿瘤上皮间质转化机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7249e53419)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483053, encodeId=2556148305379, content=<a href='/topic/show?id=5dcbe397d2' target=_blank style='color:#2F92EE;'>#FGFR#</a>, objectTitle=PLoS ONE：靶向FGFR4能够抑制肝细胞癌, objectType=article, longId=6513, objectId=2c396513d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c396513d4, replyNumber=0, likeNumber=0, createdTime=2012-05-26, rootId=0, userName=12498c24m71暂无昵称, userId=31fb7872570, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c396513d4, moduleTitle=PLoS ONE：靶向FGFR4能够抑制肝细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c396513d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

FGFR

2020-05-29

12498c24m71暂无昵称 (审核中...)

前往app查看评论内容

#FGFR#

Sci Rep：Runx2是成骨细胞祖细胞增殖所必需的，通过调节Fgfr2和Fgfr3诱导细胞增殖

2018-09-18

12498c24m71暂无昵称 (审核中...)

前往app查看评论内容

#FGFR#

JCO：BGJ398治疗FGFR改变晚期胆管癌

2017-12-01

12498c24m71暂无昵称 (审核中...)

前往app查看评论内容

#FGFR#

重磅：肝癌在研新药FGFR4抑制剂获FDA孤儿药资格

2017-10-14

12498c24m71暂无昵称 (审核中...)

前往app查看评论内容

#FGFR#

CLIN CANCER RES：FGFR1过表达肺癌原发耐药机制

2017-09-25

12498c24m71暂无昵称 (审核中...)

前往app查看评论内容

#FGFR#

CLIN CANCER RES：多韦替尼治疗BCG无反应FGFR3突变或过表达尿路上皮肿瘤Ⅱ期临床试验结果

2017-07-04

12498c24m71暂无昵称 (审核中...)

前往app查看评论内容

#FGFR#

BMC Cancer：FGFR1和FRS2α的表达增加会降低RCC患者的无进展生存期

2015-05-01

12498c24m71暂无昵称 (审核中...)

前往app查看评论内容

#FGFR#

Hepatology：miR-214下调FGFR1抑制结直肠癌肝转移

2014-03-29

12498c24m71暂无昵称 (审核中...)

前往app查看评论内容

#FGFR#

PNAS：FGFR4 ，MAP3K9和PAK5可能成为非小细胞肺癌（NSCLC）的潜在治疗靶点

2013-07-14

12498c24m71暂无昵称 (审核中...)

前往app查看评论内容

#FGFR#

Science：转化性FGFR-TACC基因融合引发恶性胶质母细胞瘤

2012-07-29

12498c24m71暂无昵称 (审核中...)

前往app查看评论内容

#FGFR#

PLoS ONE：阻断FGFR抑制肿瘤转移

2012-07-08

12498c24m71暂无昵称 (审核中...)

前往app查看评论内容

#FGFR#

PLoS One：FGFR1诱导肿瘤上皮间质转化机制

2012-07-04

12498c24m71暂无昵称 (审核中...)

前往app查看评论内容

#FGFR#

PLoS ONE：靶向FGFR4能够抑制肝细胞癌

2012-05-26

科室
- - 订阅+
  - 更多科室
工具
服务